Skip to Main Content

Paper Details

Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer.
Clin Cancer Res
6
2022
Breast Cancer, Cardiac toxicity, Cardiotoxicity, HER2, HER2 codon 655, HER2-positive breast cancer, Patients, SLC28A3, SLC28A3 gene, anthracycline, anthracyclines, breast cancer, cardiac, cardiac toxicity, codon 655, patient, patients, polymorphisms, rs1136201, rs1136201 allele, rs7853758, rs7853758 allele, trastuzumab
Author NameAffiliation
Peter A FaschingErlangen University Hospital
Richard M WeinshilboumMayo Clinic
Tadeusz Pienkowski
Liewei WangMayo Clinic
Dennis J SlamonDepartment of General Internal Medicine and Health Services Research, University of California Los Angeles
  • 1 - 5

Datasets

Release 1.2